Tissue Regenix Group
Tissue Regenix Group is a medical technology company specializing in the development and commercialization of innovative products in the field of tissue engineering and regenerative medicine. Incorporated in 2006 and based in Garforth, United Kingdom, the company operates through several divisions, including BioSurgery, Orthopaedics & Dental, and Cardiac. Tissue Regenix's core technology, dCELL, involves a decellularization process that removes DNA and cellular material from biological tissues, allowing for repopulation with the patient’s own cells, thus minimizing rejection risks and enhancing natural healing. The company offers a range of products, including DermaPure, a decellularized dermal allograft for various medical applications, and BioRinse, a natural bone filler that promotes native bone growth. Other notable products include SurgiPure XD for hernia repair and OrthoPure XT, a scaffold for tissue regeneration. With a commitment to addressing complex clinical needs, Tissue Regenix is positioned as a leader in regenerative medicine, with a strong focus on the U.S. market.
CellRight
Acquisition in 2017
CellRight Technologies, LLC is a biotechnology company based in Universal City, Texas, specializing in the development and manufacturing of regenerative medicines and osteoinductive wound care scaffolds. Founded in 2011, the company focuses on creating products that enhance healing for defects caused by trauma and disease. CellRight is recognized as an industry leader in osteoinductive matrices, offering clinically verified implants that aim to improve patient outcomes and fusion rates. Their product range includes various graft options tailored for conventional and sports medicine, enabling healthcare providers to effectively deliver treatments such as platelet-derived growth factor, bone marrow aspirate, platelet-rich plasma, and antimicrobial agents. To ensure the efficacy of their products, CellRight conducts in-vivo and in-vitro testing for osteoinductivity through independent laboratories. As of 2017, the company operates as a subsidiary of Tissue Regenix Group plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.